SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-115197
Filing Date
2020-04-23
Accepted
2020-04-22 17:40:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d918083dsc13da.htm SC 13D/A 117015
2 EX-99.2 d918083dex992.htm EX-99.2 46788
  Complete submission text file 0001193125-20-115197.txt   165712
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Subject) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-57799 | Film No.: 20808703
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 55 WILLIAM STREET SUITE 240 WELLESLEY MA 02481
Business Address 55 WILLIAM STREET SUITE 240 WELLESLEY MA 02481 781-239-0700
Ampersand 2018 Limited Partnership (Filed by) CIK: 0001734267 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A